Navigation Links
NEJM study points to new era in hepatitis C treatment
Date:6/5/2009

NEW YORK (June 4, 2009) -- For patients with the most common form of hepatitis C, the addition of a hepatitis Cspecific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

Results of the Phase IIb clinical trial -- led by Duke Clinical Research Institute (DCRI) and 36 other sites, including NewYork-Presbyterian Hospital/Weill Cornell Medical Center -- are published in the April 30th issue of the New England Journal of Medicine. The study was funded by Vertex Pharmaceuticals Incorporated, the maker of the drug telaprevir. The drug works by blocking an enzyme that the hepatitis C virus needs in order to replicate itself.

"These findings point the way to a new era in the treatment of hepatitis C," says Dr. Ira M. Jacobson, a co-author of the study and chief of the Division of Gastroenterology and Hepatology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and the Vincent Astor Distinguished Professor of Clinical Medicine at Weill Cornell Medical College. "Not only does adding telaprevir make standard hepatitis C treatment more effective, but it makes it work much more quickly. We showed that the duration of therapy can be reduced from 48 weeks to 24 weeks for most patients. This could help reduce the potentially severe side effects of longer regimens with standard therapy."

The randomized, double-blinded trial followed 250 patients with untreated hepatitis C genotype 1. Researchers measured rates of sustained viral response or viral cure -- an undetectable quantity of hepatitis C virus -- 24 weeks after the end of completion of therapy. They compared a 12-week regimen of telaprevir combined with two different durations of the standard therapy -- peginterferon alfa-2a and ribavirin -- to a control group taking 48 weeks of standard therapy alone. Results showed that 67 percent of patient
'/>"/>

Contact: Linda Kamateh
lib9027@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... (PRWEB) March 05, 2015 The recent ... weight loss promises is alarming, with more and more ... without an actual prescription, making it easy for more ... simply take their money and endanger their health. The ... before purchasing prescription online diet pills: , 1.    Where are ...
(Date:3/5/2015)... ATLANTA, GA (PRWEB) March 05, 2015 ... networking and relationship-marketing firm, honored finalists and winners ... Southeast Executive Forum and Awards Gala at the ... Chronis, chief security officer for EarthLink, was selected ... Award winner for the ISE® Southeast Region. Pete ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Considering egg ... fertility practice, is holding an informational event ... proactively plan for future families with egg freezing. , ... Plaza, 3500 Peachtree Rd, Atlanta, GA, Time: 5:30 - ... but RSVP required. Register here ! , In ...
(Date:3/5/2015)... 05, 2015 What makes a legend? In ... it’s almost 50 years of exceptional courtroom performance, championing big ... his five decades of brilliant service, the Dallas Bar Association ... Schmidt will be honored at a luncheon on Tuesday, April ... Ross Avenue. Other award nominees for this year are Bob ...
(Date:3/5/2015)... Developers and plugin specialists of Final ... transition pack entitled TranSlice Wipe for FCPX. , “TranSlice ... ease while maintaining a professional look,” Said Christina Austin, ... time saver with transitions our users will love.” , ... screen transitions with a new style. TranSlice Wipe allows ...
Breaking Medicine News(10 mins):Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 2Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 4Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 3Health News:C.L. Mike Schmidt Named "Legend In Trial Law" by Dallas Bar Association 2Health News:Pixel Film Studios Released TranSlice Wipe Exclusively for Final Cut Pro X Editors 2
... has been awarded to researchers at Queen,s to help ... likely to smoke than the general population. , It ... the scientists discover improved treatments for nicotine dependence - ... death from smoking-related diseases - as well as treatments ...
... A minimally invasive treatment for a common cause of male infertility ... new study published in the August issue of Radiology. , ... ... minimally invasive treatment for a common cause of male infertility can ...
... application of a pain-relieving gel may reduce the breast ... the results of a clinical trial published in the ... have something that we know reduces discomfort with screening ... the trial,s principal investigator, Colleen Lambertz, F.N.P., a nurse ...
... removed than men, study shows , , MONDAY, July 21 (HealthDay ... with their decision, women are much more likely than men ... , The study authors noted that the gender difference might ... more social stigma and negative comments as a result of ...
... -- Researchers from Duke University, the University of Cincinnati ... hoping to find a geographical pattern to help explain ... disease amyotrophic lateral sclerosis (ALS) at twice the normal ... layering military records of troop locations onto Gulf-area maps, ...
... kill cells on organ,s surface, spare surrounding tissue ... are being recruited for a clinical trial of a ... a cancer of the lung,s lining that,s almost always ... treatment is to remove the affected lung. , "Current ...
Cached Medicine News:Health News:Grant will help patients with schizophrenia who smoke 2Health News:Minimally Invasive Treatment Improves Male Fertility 2Health News:Minimally Invasive Treatment Improves Male Fertility 3Health News:Over-the-counter anesthetic gel puts the squeeze on mammogram pain 2Health News:Women More Likely to Have Second Thoughts on Tattoos 2Health News:Women More Likely to Have Second Thoughts on Tattoos 3Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 2Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 3Health News:Lung Cancer Trial Targets Asbestos-Related Disease 2
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) ... Outlook 2015: Accelerating growth to the next level - ... to their offering. Domestic sales improved ... caused by the market,s reaction to the new drug ... to be healthy, as the momentum continues and improving ...
(Date:3/5/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... to be held March 8-11, 2015, in ... Sapirstein , Chief Executive Officer, will provide an overview ... will be available to participate in one-on-one meetings with ...
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vwvddw/therapeutic_drug ... new report "Therapeutic Drug Monitoring - Technologies, ... This report deals with therapeutic drug ... patient care by monitoring drug levels in the ... for improving outcome. TDM is viewed as a ...
Breaking Medicine Technology:India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3ContraVir to Present at 27th Annual ROTH Conference 2Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2
Features soft, low friction sheath that extends beyond the tip....
Designed to retain the desired curve during oral intubation....
Facilitates intubation of tracheal tubes....
SunGlide™ Stylette - Green Adult. Use in 7.0 to 10mm tubes. 25/box....
Medicine Products: